Mereo BioPharma Group (MREO) Earnings Date & Reports

Get AI intraday signals

A.I. Advisor

published Earnings

MREO is expected to report earnings to fall 50.00% to 0 cents per share on November 27

Mereo BioPharma Group MREO Stock Earnings Reports

Q3'24

Est.

$-0.01

Q2'24

Missed

by $0.01

Q4'23

Est.

$-0.02

Q2'23

Est.

$-0.02

The last earnings report on August 13 showed earnings per share of -1 cents, missing the estimate of 0 cents. With 525.37K shares outstanding, the current market capitalization sits at 636.95M.

View a ticker or compare two or three

Compare

MREO

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For MREO
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for MREO (Try 14 days for $1 only)

A.I. Advisor

published General Information

General Information

a company, which engages in therapeutics that aim to improve outcomes for patients with osteogenesis imperfecta, alpha-1 antitrypsin deficiency, hypogonadotropic hypogonadism in obese men, and acute exacerbations of chronic obstructive pulmonary disease

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

One Cavendish Place

Phone

+44 3330237300

Employees

Web

https://www.mereobiopharma.com